appropriateness of PCI in contemporary practice throughout the United States. Accordingly, we analyzed data from the CathPCI registry to (1) quantify the proportion of PCIs classified as appropriate, of uncertain appropriateness, and as inappropriate for acute as well as nonacute indications; (2) identify factors and clinical scenarios associated with PCIs classified as inappropriate; and (3) assess the extent of hospital-level variation in the proportion of inappropriate PCIs classified.
METHODS

Data Sources and Appropriate Use Criteria
The design of the NCDR CathPCI Registry, sponsored by the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions, has been previously described. 8, 9 Briefly, the NCDR CathPCI registry is a national registry of diagnostic cardiac catheterization and PCI data collected from more than 1000 US sites. Detailed information on patient and hospital characteristics, coronary angiographic findings and PCIs, and inhospital outcomes is collected by trained staff at participating hospitals using standardized data elements (available from the CathPCI Registry Web site [https://www.ncdr.com/webncdr /DefaultCathPCI.aspx]). All data submissions must meet specified quality standards. 8 Patient race was selfidentified and was abstracted from the medical records by dedicated staff at each hospital.
The methodology for the appropriate use criteria for coronary revascularization has been previously described. 7 Using a modified Delphi approach, a 17-member expert panel adjudicated the appropriateness of coronary revascularization for 198 distinct and mutually exclusive clinical indications. These indications were developed to represent a diverse range of clinical situations encountered in routine practice and involved different combinations of (1) clinical presentation (acute coronary syndrome, stable coronary artery disease, prior coronary artery bypass graft surgery); (2) symptom severity (Canadian Cardiovascular Society angina class); (3) ischemia severity (low, intermediate, high) on noninvasive functional testing; (4) high-risk clinical features (eg, left ventricular dysfunction, ventricular arrhythmia); (5) intensity of antiischemic medical therapy; and (6) extent of coronary anatomical findings on angiography (significant 1-, 2-, or 3-vessel coronary artery disease with or without disease of the proximal left anterior descending artery, left main artery, or bypass graft). Significant obstructive coronary artery disease was defined as 50% or greater stenosis of the left main coronary artery or 70% or greater stenosis of a major epicardial or branch vessel 2.0 mm or greater in diameter. 7 For each clinical indication, technical panel members of the appropriate use criteria independently assessed the expected gains in survival or health status (symptoms, function, or quality of life) relative to the risks of the procedure 7 based on clinical practice guidelines, published literature, and their expert opinion. They then assigned ratings from 1 (least appropriate) to 9 (most appropriate). From the median of the individual ratings of the 17 technical panel members, each clinical indication was classified as appropriate (median, 7-9), uncertain (median, 4-6), or inappropriate (median, 1-3). In the published appropriate use criteria, an "appropriate" rating denoted that coronary revascularization would likely improve a patient's health status (symptoms, function, or quality of life) or survival; an "uncertain" rating implied that more research, more patient information, or both was needed to further classify the indication; and an "inappropriate" rating denoted that coronary revascularization was unlikely to improve the patient's health status or survival.
7
Study Population
In anticipation of the publication of the appropriate use criteria for coronary revascularization, the NCDR CathPCI Registry revised its data collection form to ensure that the requisite data elements to assess procedural appropriateness could be prospectively collected. These data then allowed for each PCI to be assigned to an appropriate use criteria indication, and the appropriateness rating for that indication determined the appropriateness of a PCI. In the rare circumstance in which a patient could be assigned to more than 1 indication, the indication with the highest appropriateness rating was used. The accuracy of the algorithms to match PCIs to appropriate use criteria indications was ascertained by manual mapping of 200 randomly generated nonacute procedures by an investigator (P.S.C.) blinded to the algorithm results, in which we found 100% concordance in appropriateness assignments between the algorithms and the manual match. In addition, the NCDR conducted separate manual mapping of 127 inappropriate PCIs at 11 sites and also found 100% concordance in appropriateness assignments. Details of the mapping algorithm are available from the American College of Cardiology NCDR program.
For this study, we evaluated the appropriateness of 602 781 PCIs submitted to the NCDR between July 1, 2009, and September 30, 2010, following the implementation of this new version (4.0) of the NCDR CathPCI data collection form. Acute indications for PCI were defined as those performed in the setting of an acute coronary syndrome, including all myocardial infarctions (ST-segment elevation and non-ST-segment elevation myocardial infarction), as well as unstable angina with high-risk features. High-risk unstable angina was defined by the appropriate use criteria as accelerating tempo of ischemic symptoms or prolonged ongoing rest pain with additional high-risk clinical features, such as new or worsening pulmonary edema, transient ST-segment changes, new bundle-branch block, sustained ventricular tachycardia, or hypotension.
All other PCIs were considered as having been performed for nonacute indications.
The institutional review board at Saint Luke's Mid America Heart and Vascular Institute granted a waiver of written informed consent and provided authorization for this study.
We were able to classify 500 154 PCIs (83.0%) from 1091 hospitals to an appropriate use criteria indication, and these procedures constituted the study cohort (FIGURE 1). Excluded procedures were those in which the requisite data for mapping patients were not available, primarily because of the absence of noninvasive stress test results for nonacute procedures. Specifically, these included 16 853 staged PCI procedures (2.8%), 9752 patients (1.6%) presenting with unstable angina without high-risk features who proceeded directly to coronary angiography, and 24 741 patients (4.1%) without any prior noninvasive testing. Also excluded were 43 521 nonacute PCIs (7.2%) in which a preprocedural stress test was performed but the results were unknown. These latter patients were included in our sensitivity analyses. The remaining exclusions comprised 2228 nonacute procedures (0.4%) with coronary calcium or computed tomography angiographic testing but without an ischemia assessment, 3762 nonacute procedures (0.6%) with missing information on symptoms or angiographic data, and 1770 acute procedures (0.3%) in which patients with an ST-segment elevation myocardial infarction were successfully treated with fibrinolytic therapy but had missing data on symptoms after fibrinolysis but before PCI.
Statistical Analysis
The proportion of PCIs classified as appropriate, uncertain, or inappropriate was determined, stratified by acute vs nonacute indication. Baseline demographic characteristics and clinical variables (risk factors and comorbid conditions, symptoms, anti-ischemic therapy, and results from noninvasive and angiographic studies) of patients undergoing PCI were then compared by appropriateness category. Continuous variables were evaluated using analysis of variance and categorical variables with the 2 test. Because patients undergoing nonacute PCIs with incomplete information on ischemia risk were excluded, we conducted a sensitivity analysis in which these procedures were included and assigned a value for noninvasive testing of either high-risk or low-risk ischemia, which provides a best-case and worst-case estimate for the range of appropriateness ratings.
To examine the extent of hospitallevel variation for inappropriate procedures, we included only those hospitals with at least 10 nonacute procedures per year (478 procedures [0.3%] from 113 hospitals excluded). Procedures were aggregated by appropriateness category within each hospital, and the distribution in rates of inappropriate PCIs across hospitals was examined separately for acute and nonacute indications. We then examined the extent to which variations in rates of inappropriate PCIs were explained at the hospital level by determining the median rate ratio (RR), [10] [11] [12] derived using multivariable hierarchical regression with only patient-level factors included. The median RR can be interpreted as the likelihood that 2 patients with identical clinical features presenting to separate, randomly chosen hospitals would receive a PCI for an inappropriate indication at one of the hospitals as compared with the other. A median RR of 1 suggests no variation between hospitals. To ensure the robustness of the hospital-level variation findings we repeated the above analyses, including only those hospitals with at least 200 nonacute procedures annually.
In addition, for hospitals with at least 10 nonacute PCIs annually, we examined the relationship between the annual nonacute PCI volume at a hospital and the hospital's rate of inappropriate PCIs for nonacute indications using Spearman correlations. The variance in inappropriate PCIs accounted for by a hospital's case volume was assessed by determining the R 2 statistic. Lastly, the relationship between hospital status (private vs public) and the hospital rate of inappropriate PCIs in nonacute settings was displayed using box plots and evaluated using hierarchical linear regression models.
All tests for statistical significance were 2-tailed and evaluated at a signifi- Despite significant hospital variation, the relationship between a hospital's annual nonacute PCI volume and its rate of inappropriate PCI was weak (Spearman correlation, 0.06), accounting for less than 0.4% of the variance in rates of inappropriate PCIs ( Figure 2B) . Moreover, the median hospital rate of inappropriate PCIs was similar between private hospitals (n = 457 [47%]) and public hospitals (n = 521 [53%]) (eFigure, available at http://www.jama.com), and private hospitals were not more likely 4 by explicitly and prospectively collecting detailed clinical information about the indications for PCI at more than 1000 US hospitals. Importantly, because our assessments of PCI appropriateness were conducted before the NCDR Cath-PCI Registry had presented the data to participating centers, we believe that our findings reflect contemporary practice and provide important benchmarks for future assessments of procedural appropriateness at the national and hospital level.
Most of the nonacute procedures classified as inappropriate were performed in settings in which the benefit of PCI has not been demonstrated. For instance, 98.5% of patients undergoing an inappropriate PCI in the nonacute setting were In Table 4 , we have outlined the 5 most common appropriate use criteria indications for an inappropriate nonacute PCI. Although some of the inappropriate procedures may be explained by extenuating circumstances (eg, highrisk coronary anatomical findings not captured in the appropriate use criteria), these factors are expected to be uncommon and should not account for the majority of procedures classified as inappropriate. It is also possible that patient preferences may influence physician decisions about coronary revascularization.
14 However, recent studies have found that patients often overestimate the benefits of PCI, 15 and most PCIs are performed ad hoc (immediately following diagnostic angiography), which limits the opportunity for informed discussions with patients about the relative benefits and risks of PCI. 16, 17 Rather, it is likely that clinician factors are responsible for many of these procedures. Our previous finding of substantial variation in rates of agreement in appropriateness assignments (range, 5%-76%) between individual cardiologists and the technical panel of the appropriate use criteria 18 further supports this hypothesis. This suggests a need for further education of physicians about procedural appropriateness to improve patient selection in the nonacute setting.
A major finding of this study was that rates of inappropriate PCI varied markedly at the hospital level. Although some degree of inappropriate PCI use may be attributable to limitations in the appropriate use criteria methodology (eg, high-risk coronary anatomical findings or clinical features not captured in the appropriate use criteria), 7 it is unlikely that the proportion of such exceptional cases would vary substantially across hospitals. The bestperforming hospitals had 6% or fewer of their nonacute PCIs classified as inappropriate, suggesting that a low hospital rate for inappropriate PCIs is achievable. However, 25% of hospitals had at least 1 in 6 of their nonacute procedures classified as inappropriate, which suggests overuse of PCI in these hospitals and an important opportunity for improvement in patient selection. One strategy for improvement might be the development of additional decision tools that can provide physicians performing the diagnostic coronary angiogram with realtime guidance about the appropriateness of proceeding to PCI.
Our findings also point toward new challenges and directions required for assessing the overall appropriateness of PCI. For instance, a substantial number of procedures were performed in nonacute settings in which proce- dural appropriateness was uncertain. Although 64% of these patients had intermediate or high-risk ischemia on noninvasive testing, only 12% had severe (class III or IV) angina (Table 3 ). The rating of uncertain appropriateness therefore suggests that there were insufficient data for the technical panel of the appropriate use criteria to conclude that the benefits of PCI, compared with medications alone, would justify the risk and cost of PCI for these indications.
Indications with uncertain appropriateness represent gaps in knowledge and underscore the need for future outcomes-based studies to clarify the benefits of PCI. In addition, although our analyses were conducted prior to hospitals' knowledge about their rates of procedural appropriateness, future studies of procedural appropriateness will need to account for potential "gaming" of key variables used in appropriateness assessments, such as symptom severity. The use of objective and validated patient-centered health status questionnaires to assess angina and routine data audits would help to facilitate the integrity of future appropriateness assessments.
Our study should be interpreted in the context of the following limitations. First, not all hospitals that perform PCI in the United States participate in the NCDR CathPCI Registry. Our analyses, however, were conducted in a patient sample from more than 1000 hospitals, and our results are currently the most complete assessment of practice patterns throughout the United States. Second, while we examined potential overuse of PCI (ie, inappropriate PCI) within the appropriate use criteria, we were unable to evaluate underuse of PCI-another important component of procedural appropriateness.
Third, we excluded nonacute procedures because of unavailable ischemia risk assessment results, which precluded an assignment of procedural appropriateness. Our sensitivity analyses showed that the rate of appropriate PCIs in the nonacute setting would increase only modestly, from 50% to 58%, even if we ascribed high-risk ischemia results to patients with incomplete information on ischemia risk. Conversely, the rate of inappropriate PCIs in the nonacute setting increased to 21% when we ascribed low-risk ischemia to each of these patients. Fourth, it is possible that hospitals may have inflated their rates of appropriate PCI by reporting more severe symptoms and stress test results; however, this is unlikely, because the period of analysis in this study preceded feedback reports to hospitals about their rates of inappropriate procedures.
Fifth, we were able to categorize PCIs in which assessments of fractional flow reserve were used in the evaluation of coronary artery stenoses between 50% and 60%. However, the use of fractional flow reserve in coronary artery stenoses of greater than 60% were not adjudicated in the appropriate use criteria, which may account for some of the procedures excluded because of no ischemia assessment. Lastly, the appropriate use criteria reflect a synthesis of contemporary clinical trial evidence, clinical practice guidelines, and expert opinion. Some PCIs classified as uncertain or inappropriate may be a p p r o p r i a t e w h e n c o n s i d e r i n g unique clinical and patient factors (eg, coronary anatomy not covered by the indications); likewise, some procedures classified as appropriate may be inappropriate in a particular clinical situation (eg, patient with limited life expectancy or end-stage renal disease). Although it is possible that certain factors may lead to a reclassification of procedural appropriateness, this is likely to be uncommon and would not explain the substantial variation in rates of inappropriate procedures across hospitals.
I n c o n c l u s i o n , i n t h i s l a r g e national registry, nearly all PCIs performed for acute indications were appropriate. However, for nonacute indications, the rate of inappropriate procedures was 12%, with the majority of these procedures performed in patients with little to no angina or with low-risk ischemia on stress testing. Moreover, there was substantial hospital variation in the rate of inappropriate PCI for nonacute indications. Better understanding of the clinical settings in which inappropriate PCIs occur and reduction in their variation across hospitals should be targets for quality improvement. Only hospitals with at least 10 nonacute PCIs annually were included (499 676 PCIs, 978 sites); 478 PCIs from 113 low-volume hospitals were excluded. The distribution of hospital rates was similar when analyses were restricted to hospitals with a minimum of 200 nonacute PCIs annually (see "Methods"). B, Relationship between a hospital's nonacute PCI volume and its rate of inappropriate PCI in the nonacute setting.
